Proof of ownership and provenance of gene-edited biological assets.

GitLife Biotech technology has developed a Version Control System and Biosecurity Toolkit that uses novel DNA barcodes and watermarks to connect biological assets to digital records stored securely on our B2B SaaS VCS platform: cellrepo.com. To date, synthetic biologists have relied on legal contracts, which are expensive and subjective, and patenting, which requires the full DNA sequence to be disclosed to the world.

GitLife Biotech gives owners of biological assets full protection, allowing them to collaborate and monetise effectively, and solving the reproducibility crisis - underpinning significant scale in the synthetic biology industry.